Press release
Myocardial Infarction Therapeutics Market Analysis, Segments, Growth and Value Chain 2016-2026
Myocardial infarction, generally called as heart attack is characterized by reduced blood supply to the heart muscles, primarily due to coronary artery disease. According to American Heart Association (AHA), every year around 17.3 Mn people die of heart diseases worldwide, with myocardial infarction being the leading cause of death. In 2012, British Heart Foundation reported 73,680 deaths in United Kingdom due to coronary heart disease. Mortality from acute myocardial infarction can be decreased if patient receives the emergency access to the treatment. The global cardiovascular treatment market generated a revenue of 170 Bn in 2010 and is expected to expand drastically over the forecast period of 2016-2026. Multitude of products available for the treatment of acute myocardial infarction with different indications include Zorprin, Plavix, Angiomax, Diovan, Lovenox, Aggrastat, NitroStat, Benicar and many more.
Myocardial Infarction Therapeutics Market: Drivers and Restraints
Increasing incidence of coronary artery disease and changes in lifestyle are the major factors expected to drive the growth of global myocardial infarction therapeutics market. Increasing number of smokers, increasing incidence of obesity and blood pressures, lack of exercise can be some other reasons likely to flourish the global myocardial infarction therapeutics market over the forecast period of 2016-2026. WHO findings show that the death rate due to cardiovascular diseases is more in smokers than that in non-smokers. Whereas, saturation in R&D can be the major restraint for the growth of global myocardial infarction therapeutics market.
Myocardial Infarction Therapeutics Market: Segmentation
The global myocardial infarction therapeutics market has been classified on the basis product type, distribution channel and geography.
Based on product type, the global myocardial infarction therapeutics market is divided into following:
Analgesics
Antiplatelet agents
Vasodilators
Thrombolytics and anti-thrombotic agents
Glycoprotein IIb/IIIa inhibitors
Î’ adrenergic blockers
Angiotensin receptor antagonists
Angiotensin converting enzyme inhibitors
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1263
Based on distribution channel, the global blood canner treatment market is divided into following:
Hospitals
Hospital Pharmacies
Drug Stores
Online drug stores
Myocardial Infarction Therapeutics Market: Overview
Analgesics and antiplatelet agents’ segments are foreseen to hold more share in global myocardial infarction therapeutics market as these agents are used for initial treatment of an acute myocardial infarction. Amongst sales channels, hospital pharmacy segment is expected to contribute more into global myocardial infarction therapeutics market. The global myocardial infarction therapeutics market is foreseen to experience the boost in market volume over the forecast period due to the launch of several new products such as Apixaban, Xarelto and introduction of generic drugs after expiration of patents for Crestor and Benicar.
Myocardial Infarction Therapeutics Market: Regional Overview
Geographically, the global myocardial infarction terapeutic market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America will continue to take leading position in global myocardial infarction therapeutic market owing to expanding aging population and prevalence of co-morbidities. The expiry of blockbuster drugs in European market is likely to deter the segment share in global myocardial infarction therapeutics market. Japan is expected to experience the stagnancy in global myocardial infarction therapeutics market, in part due to saturation in R&D.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1263
Myocardial Infarction Therapeutics Market: Key Players
Some of the key players in global myocardial infarction therapeutics market are Novartis N.V., Daiichi Sankyo Company Limited, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, AstraZeneca, Apotex Inc., Sandoz, Par Pharmaceutical Companies, Inc., Mylan N.V., Pfizer Inc.
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature.
Mr. Sudip saha
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myocardial Infarction Therapeutics Market Analysis, Segments, Growth and Value Chain 2016-2026 here
News-ID: 330875 • Views: …
More Releases from FMI Reports
Research report covers the Triallyl Isocyanurate Market Growth, 2016-2026
Future Market Insights has announced the addition of the “Triallyl Isocyanurate Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Triallyl isocyanurate is used as a cross linking in the manufacture of agrochemicals, flame retardants and synthetic rubbers. It is synthesized by gradually adding cyanuric chloride to excess of alcohol or allyl chloride in the presence concentrated aqueous phase. For various applications, triallyl isocyanurate can be…
Structured Cabling Market Growth and Segments,2016-2026
Future Market Insights has announced the addition of the “Structured Cabling Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Structured cabling system is defined as the combination of set of cables & associated hardware used to provide comprehensive telecommunication infrastructure to various management systems, this telecommunication infrastructure enables the transmission of data, voice & video signal through a communication network from one point to other…
Polyetheramine Market, 2016-2026 by Segmentation: Based on Product, Based on App …
Future Market Insights has announced the addition of the “Polyetheramine Market: Global Industry Analysis and Opportunity Assessment 2016-2026" report to their offering.
Polyetheramines are typically the curing agents which contain polyether and amine moieties, are majorly used to increase toughness, flexibility, hydrophobicity or hydrophilicity of the end-products. Polyetheramines are used for a range of applications including polyurea, epoxy curing and polyamides in a range of coatings. Polyetheramines are also…
Immunochemistry Analyzer Market Regulations and Competitive Landscape Outlook to …
Future Market Insights has announced the addition of the “Immunochemistry Analyzer Market: Global Industry Analysis and Opportunity Assessment 2015-2025" report to their offering.
Immunochemistry analyzer are becoming more and more popular in the global clinical chemistry and immunoassay as these are proved to be very effective tool to diagnose cancer, hepatitis, illegal drugs, fertility problems, sodium levels, endocrine function, and the detection of blood clots.
There are approximately more than 180,000 immunochemistry…
More Releases for Myocardial
Myocardial Infarction Drugs Market
According to a new report published by Allied Market Research, titled, "Myocardial Infarction Drugs Market by Product Type (Analgesics, Antiplatelet Agents, Vasodilators, Thrombolytics, Anti-Thrombotic Agents, Glycoprotein IIb/IIIa Inhibitors, Î' Adrenergic Blockers, Angiotensin Receptor Blockers, and Angiotensin Converting Enzyme Inhibitors) and by Distribution Channel (Hospital Pharmacies, Hospitals, Drug Stores, and Online Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2019-2026".
The Global market size of Myocardial Infarction Drugs Market was $XX…
Post-Myocardial Infarction Market rake higher revenue in 2025
Global Post-Myocardial Infarction Market: Overview
The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are…
Post-Myocardial Infarction Market Foretell Optimal Growth by 2025
Global Post-Myocardial Infarction Market: Overview
The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are…
Myocardial Ischemia Market to Record Ascending Growth
Myocardial ischemia is characterized by a specific condition, where there is an insufficient flow of blood to the heart muscle (myocardium) through coronary arteries. Due to an obstruction or constriction of the arteries, the heart is not able to pump oxygenated blood and other vital nutrients to the body efficiently and finally leads to destruction of the heart muscles. Blockage of an artery (due to atherosclerotic plaque), blood clots, heart…
Post-Myocardial Infarction Market - Vendor Landscape & Forecast 2017 - 2025
Global Post-Myocardial Infarction Market: Overview
The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are…
Myocardial Ischemia - Pipeline Review, H1 2017
MarketResearchReports.Biz presents this most up-to-date research on "Myocardial Ischemia - Pipeline Review, H1 2017"
Description
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Ischemia - Pipeline Review, H1 2017, provides an overview of the Myocardial Ischemia (Cardiovascular) pipeline landscape.
Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side…
